An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 38: ETFDH (4q32.1)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs4690909 octanoylcarnitine / X-13435 C/G 6520 0.69 0.056 (0.004) 1.76·10-57 show
rs8396 decanoylcarnitine T/C 7320 0.7 0.053 (0.004) 8.69·10-38 show
rs8396 octanoylcarnitine T/C 7345 0.7 0.048 (0.004) 1.38·10-31 show
rs8396 cis-4-decenoyl carnitine T/C 7219 0.7 0.026 (0.004) 8.96·10-13 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs4690909
Chromosomal locationChr4: 159,848,601 (4q32.1)
Gene (distance)ETFDH (0)
Predicted causal geneETFDH
Gene/protein classification-
Metabolite (Pathway)octanoylcarnitine (Carnitine metabolism; Lipid)
X-13435 (Unknown)
Biochemical locus-metabolite relationshipETFDH encodes a mitochondrial electron transfer flavoprotein dehydrogenase which is essential for electron transfer from the short-, medium- and long-chain acyl-CoA dehydrogenases. Mutations in ETFDH lead to multiple acyl-CoA dehydrogenase deficiency, which is characterized by elevated short-, medium- and long-chain acyl carnitines [17412732]. Ratio interpretation: octanoylcarnitine is a substrate. X-13435 is most probably a 10:1 carnitine and may normalize for the medium chain length carnitine pool (possible 'normalizing')
eQTL associationsETFDH (F), ETFDH (L), ETFDH (S) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associations-
Known metabolite associationsdecanoylcarnitine [21886157]; C14:1-OH/C10 [20037589]
Inborn error of metabolismGlutaric acidemia type II

Pharmacological information
ChEMBL ID-
Drug information -

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map